News
10d
MarketBeat on MSN3 Biopharmaceutical Stocks Bucking the Sell-OffWith tariffs sending markets reeling in the first days of the second quarter—the S&P 500 dropped roughly 10% in the five ...
This irresponsible form of political theater is on display regarding the necessary and critical role capital investing plays ...
After a batch of much-anticipated reciprocal tariffs spared pharmaceuticals in early April, drugmakers, medtech companie | ...
Looking for a biopharma job in Massachusetts? Check out the BioSpace list of nine companies hiring life sciences ...
The initial public offerings (IPOs) in the biopharmaceutical sector surged 68.4 per cent to reach $8.52 billion globally in ...
A biopharmaceutical company that makes treatments for depression is growing to nearly 100K SF at the Western Hemisphere's tallest building. Axsome Therapeutics signed a 96K SF sublease deal at One ...
Protagonist Therapeutics, Inc. (”Protagonist” or the “Company”), a clinical-stage biopharmaceutical company pioneering the discovery and development of peptide-based therapeutics, today announced that ...
In the wake of unprecedented workforce cuts at the FDA, former Commissioner Scott Gottlieb and an unnamed former CBER ...
RedHill Biopharma (RDHL) announced that the Company received a written notification from the Listing Qualifications Department of the Nasdaq ...
New C&DIs related to Reg A and Reg D - On March 12, the Securities and Exchange Commission (SEC) Division of Corporation Finance ...
RedChip Companies will air interviews with Bullfrog AI Holdings, Inc. (Nasdaq:BFRG) and Connect Biopharma Holdings Limited (Nasdaq:CNTB) and on the RedChip Small Stocks, Big Money™ show, a sponsored ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results